AI Advances in Hypertrophic Cardiomyopathy Diagnosis

Hypertrophic cardiomyopathy (HCM), a prevalent genetic cardiovascular disorder characterized by thickening of the left ventricle, is increasingly benefiting from advancements in artificial intelligence (AI), particularly deep learning (DL). These technologies offer the potential for more accurate and efficient diagnosis, moving beyond traditional methods like Late Gadolinium Enhancement (LGE) cardiac magnetic resonance (CMR), which has limitations including gadolinium retention in the brain.

The Challenges of Traditional Diagnosis

Historically, differentiating HCM from other conditions like hypertensive heart disease (HHD) has been challenging. Global native T1 mapping, a previous diagnostic approach, has shown modest discrimination performance. Radiomics, while promising, requires extensive feature extraction, a time-consuming and complex process. These limitations highlight the need for more streamlined and accurate diagnostic tools.

Deep Learning: A Promising Recent Approach

Deep learning (DL) is emerging as a powerful technique for differential diagnosis in cardiology. Recent research demonstrates the feasibility of using DL to differentiate HCM and HHD based on T1 images. Studies have shown that DL models analyzing myocardial tissue can achieve high diagnostic accuracy.

ResNet32 and Diagnostic Performance

One study utilized a ResNet32 deep learning network to analyze T1 images. Different input methods were tested, including focusing on the myocardial ring (DL-myo), the myocardial ring bounding box (DL-box), and surrounding tissue without the myocardial ring (DL-nomyo). The results were compelling:

• DL-myo: Achieved an Area Under the Curve (AUC) of 0.830 (95% confidence interval: 0.702-0.959)
• DL-box: Achieved an AUC of 0.766 (95% confidence interval: 0.617-0.915)
• DL-nomyo: Achieved an AUC of 0.795 (95% confidence interval: 0.654-0.936)

For comparison, native T1 mapping and radiomics achieved AUCs of 0.545 (0.352-0.738) and 0.800 (0.655-0.944), respectively, in the same testing set. These findings suggest that DL models, particularly those focusing on the myocardial ring, can outperform traditional methods.

Non-Contrast MRI and Coronary Microcirculatory Dysfunction

Beyond general HCM diagnosis, AI is also being applied to detect coronary microcirculatory dysfunction (CMD) in HCM patients. Traditionally, CMD detection relies on contrast-enhanced cardiac MRI. However, a new approach focuses on developing non-contrast radiomics models to minimize reliance on contrast agents, addressing concerns about potential side effects.

Researchers are utilizing logistic regression and machine learning algorithms, including Random Forest, to analyze images from cine, T1 mapping, and T2 fat-saturation sequences. This allows for the identification of predictive imaging features without the need for contrast agents.

Semi-Supervised Learning and Foundation Models

A significant challenge in medical image analysis is the need for large-scale labeled datasets for training AI models. However, obtaining these annotations is often difficult and requires the expertise of medical specialists. To address this, researchers are exploring semi-supervised learning techniques, which leverage both labeled and unlabeled data.

Recent advancements include the application of foundation models, such as Segment Anything, to medical image segmentation. These models, pre-trained on vast datasets, can be adapted to specific medical tasks with limited labeled data, offering a promising path toward more efficient and accurate AI-powered diagnostics.

Future Directions

The integration of AI into HCM diagnosis is rapidly evolving. Future research will likely focus on refining DL models, expanding the leverage of non-contrast imaging techniques, and leveraging the power of foundation models to overcome data limitations. These advancements promise to improve the accuracy, efficiency, and accessibility of HCM diagnosis, ultimately leading to better patient care.